Search Browse Earnings

LeonaBio, Inc. — SlamSEC

LeonaBio, Inc.

Nasdaq:LONA

Biological Products, (No Diagnostic Substances)·BOTHELL, WA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$124.5M

FY 2024

Net Income

-$117.7M

FY 2024

EPS (Diluted)

-$3.09

FY 2024

Stock Price

$6.58

+6.5%

2026-03-10

52W Range

$2.20 – $8.36

P/E Ratio

-2.1x

Market Cap

$26.0M

Cash

$90.6M

FY 2024

Total Debt

—

Net Cash

$90.6M

Enterprise Value

-$64.6M

Debt / EBITDA

0.7x

FY 2024

EV / EBITDA

0.5x

Employees

—